DELAET INGRID (Chief Regulatory Officer) sold 21.2% of their position (4.37K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $790.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/13/2026ACC: 0001965808-26-000013
Officer· Chief Regulatory Officer
Since Feb 2026
-4.37K
Net shares
Net seller
$790.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.37K acquired · 8.73K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.37K
Price / share
$106.02
Trade value
$462.99K
% of position
26.9%
7/10/2026
16.23K→20.59K
Common Stock
Direct
Shares
−4.37K
Price / share
$181.02
Trade value
$790.51K
% of position
21.2%
7/10/2026
20.59K→16.23K
Total
Net shares
+0.00
Net value
-$327.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2026 | M · Option Exercise | +4.37K | $106.02 | $462.99K | 26.9% | 16.23K | 20.59K |
| Common Stock Direct | 7/10/2026 | S · Sale | −4.37K | $181.02 | $790.51K | 21.2% | 20.59K | 16.23K |
| Total | +0.00 | -$327.53K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
4.37K shares
Shares
−4.37K
Strike price
106.02
Held after
0.00
Exercisable
—
7/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock4.37K shares | 7/10/2026 | M · Option Exercise | −4.37K | 106.02 | — | 0.00 |